What is Monte Rosa Therapeutics, Inc.'s asset turnover?

Monte Rosa Therapeutics, Inc. (GLUE) reported asset turnover of 0.1× in Q1 2026.

How has Monte Rosa Therapeutics, Inc.'s asset turnover changed year-over-year?

Monte Rosa Therapeutics, Inc.'s asset turnover decreased by 84.3% year-over-year, from 0.5× to 0.1×.

What does asset turnover mean?

Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.

Monte Rosa Therapeutics, Inc. GLUE Asset turnover

Asset turnover at other companies

Bristol-Myers SquibbBMY

0.5×0.0×

Nurix Therapeutics, Inc.NRIX

0.1×0.0×

Kymera TherapeuticsKYMR

0×0.0×

ImmunomeIMNM

0×0.0×

Adaptive BiotechnologiesADPT

0.6×+0.2×

Arcus BiosciencesRCUS

0.2×+0.1×

Other financials

Income statement

See full

Revenue$4.2M-95.0%

Operating income-$50.0M-214%

Net income-$44.5M-195%

EPS (diluted)-$0.45-179%

Balance sheet

See full

Cash & equivalents$159.9M+104%

Total debt$39.1M-6.7%

Total equity$521.9M+89.7%

Total assets$736.4M+87.3%

Cash flow

See full

Operating cash flow-$37.4M+17.9%

CapEx$1.9M+17.7%

Free cash flow-$39.2M+16.7%

Valuation

See full

Market cap$1.75B+361%

Enterprise value$1.63B+381%

P/S40.7×+38.4×

Profitability

See full

Operating margin-345.2%—

Net margin-302.6%—

FCF margin-45.8%-64.9pp

Returns & leverage

See full

Return on equity-32.6%—

Debt / equity0.1×-0.1×

Current ratio9.5×+3.9×

Where this comes from

Calculated from Monte Rosa Therapeutics, Inc.’s reported figures.

total revenue/total assets=0.1×

Based on trailing twelve months.

The official record: Monte Rosa Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Monte Rosa Therapeutics, Inc.'s asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Monte Rosa Therapeutics, Inc.'s asset turnover?: Monte Rosa Therapeutics, Inc. (GLUE) reported asset turnover of 0.1× in Q1 2026.
How has Monte Rosa Therapeutics, Inc.'s asset turnover changed year-over-year?: Monte Rosa Therapeutics, Inc.'s asset turnover decreased by 84.3% year-over-year, from 0.5× to 0.1×.
What does asset turnover mean?: Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.